SERMORELIN

Sermorelin Product Description — Research Use Only

Sermorelin is a synthetic research peptide analog of growth hormone-releasing hormone, commonly known as GHRH. It is commonly studied for growth hormone signaling, pituitary response, IGF-1 pathway activity, recovery-related pathways, metabolic function, and body-composition research.

Research on Sermorelin has most commonly focused on growth hormone release, pituitary signaling, IGF-1 activity, GH pulse research, tissue-maintenance pathways, fat-metabolism research, and endocrine-response markers. Sermorelin represents the biologically active portion of GHRH and is studied for how it may stimulate the pituitary to release growth hormone through natural GH-axis signaling.

Sermorelin is commonly studied for:

• Growth hormone signaling — how the pituitary releases growth hormone

• Pituitary response — how the pituitary reacts to GHRH-like signals

• IGF-1 pathways — how GH signaling may influence IGF-1-related activity

• GH pulse research — how natural growth hormone release patterns are studied

• Recovery pathways — signals connected to repair, restoration, and tissue maintenance

• Metabolic research — how energy use and fuel balance are studied

• Body-composition research — markers related to lean mass, fat mass, and energy balance

Sermorelin is commonly studied because it works through GHRH-related pituitary signaling rather than supplying growth hormone directly. This makes it useful in research involving GH-axis regulation, pituitary responsiveness, IGF-1-related activity, endocrine feedback, recovery-related signaling, and metabolic pathway studies.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.